Tocqueville Asset Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,500
Closed -$303K 570
2025
Q4
$303K Buy
+4,500
New +$303K ﹤0.01% 514
2023
Q4
Sell
-5,900
Closed -$225K 532
2023
Q3
$225K Buy
+5,900
New +$242K ﹤0.01% 479

Other funds holding HALO

Tocqueville Asset Management's HALO Position: Q1 2026 in Review

Tocqueville Asset Management sold out of Halozyme (HALO) in Q1 2026, closing a stake of 4,500 shares — an estimated $303K sold.

Tocqueville Asset Management first reported a position in HALO in Q3 2023 and held it in 2 quarters. The position peaked at $303K in Q4 2025. 636 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Tocqueville Asset Management reported no remaining Halozyme position as of Q1 2026 after selling out during the quarter.
  • Tocqueville Asset Management sold 4,500 Halozyme shares in Q1 2026, an estimated $303K.
  • Tocqueville Asset Management first reported a position in Halozyme in Q3 2023 and held it in 2 quarters.
  • Tocqueville Asset Management's Halozyme position peaked at $303K in Q4 2025.
  • 636 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Tocqueville Asset Management's 13F filing for Q1 2026, filed 12 May 2026.